Physician profile
Joseph Cote
NPI 1841810017
$6,077.74
in general payments reported to CMS, 2019-2025
19 companies · $1,404 in 2025
The $1,404 reported for 2025 was more than what 85% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,318 · 2022: $136 · 2023: $2,252 · 2024: $968 · 2025: $1,404.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,760 · Travel and Lodging: $1,864.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,760.32 |
| Travel and Lodging | $1,863.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,577.45 | 2023-2025 | Prostep, Hoffmann, T2 |
| Team 1, LLC | $1,200.00 | 2021 | |
| Medical Device Business Services, INC. | $1,066.82 | 2023-2024 | Fibulink |
| Smith+Nephew, INC. | $833.38 | 2021-2025 | Stravix, Grafix, Pico 14 |
| Depuy Synthes Sales INC. | $807.29 | 2023-2024 | Motoband, Na, Fibergraft Aeridyan Matrix |
| Horizon Therapeutics Plc | $114.78 | 2022 | |
| Kerecis Limited | $91.69 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Integra Lifesciences Corporation | $79.08 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Biocomposites INC | $50.56 | 2024 | |
| Acera Surgical, INC. | $39.14 | 2025 | Restrata Wound Matrix |
| Treace Medical Concepts, INC. | $37.94 | 2022-2024 | |
| Orthofix Medical, INC. | $33.13 | 2025 | Physio-Stim |
| Convatec INC. | $33.03 | 2025 | |
| Ibsa Pharma INC. | $24.28 | 2024 | Licart, Tirosint |
| Tactile Systems Technology INC | $22.57 | 2024 | Flexitouch Plus, Entre Plus |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $20.70 | 2024 | Prevena, V.A.C. Veraflo |
| Zimmer Biomet Holdings, INC. | $16.92 | 2025 | Tapestry |
| Paratek Pharmaceuticals, INC. | $15.41 | 2025 | Nuzyra |
| Boston Scientific Corporation | $13.57 | 2024 | Wavewriter Alpha Prime 16 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Cote listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.